Pharmaceutical Executive
March 01, 2011
Issue PDF
0
0
Castellani Takes Charge at PhRMA
March 01, 2011
0
0
Boehringer Ingelheim's PICASSO program helps it focus on engaging industry stakeholders to improve patient care
March 01, 2011
0
0
Despite its dimunitive size, the pharmaceutical industry looks to the Netherlands for a world-class medical infrastructure, new standards in innovation, and a closely-knit community of stakeholders
March 01, 2011
0
0
Ferring finds a new approach to communicate its value offering
March 01, 2011
0
0
Ipsen is redefining a standard for success in innovation with its local Dutch affiliate
March 01, 2011
Columns
0
0
With an emphasis on short-term objectives rather than long-term goals, pharma is missing a huge opportunity in applying market science to drive adherence
March 01, 2011
Features
0
0
A highlight of the Hay Group's annual study of Sales Force Effectiveness, focusing on managed care markets
March 01, 2011
From the Editor
0
0
Pharma can be an insular industry, with limited capacity to gaze beyond its own narrow frame of vision
March 01, 2011
Features
0
0
Pharm Exec's annual feature applauding the people behind the best of pharma advertising over the past year
March 01, 2011
Columns
0
0
Negative views regarding pharma are on the rise, but vaccines help keep the focus on the positives of innovation
March 01, 2011
Columns
0
0
FDA's Sentinel Initiative raises broader questions about tapping patient information and health IT for comparative studies in drug development
March 01, 2011
Columns
0
0
The Federal Circuit court continues its trend in tightening the standards for establishing patent damages by leapfrogging a stalled legislative process
March 01, 2011
Features
0
0
Can PhRMA's own business model synch with industry's Pharm Exec takes a closer look at PhRMA's new leadership.